Showing 19,401 - 19,420 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant all) OR (significant i)) decrease ))', query time: 0.75s Refine Results
  1. 19401

    Table 10_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”
  2. 19402

    Table 3_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”
  3. 19403

    Table 8_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”
  4. 19404

    Table 6_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”
  5. 19405

    Table 5_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”
  6. 19406

    Table 4_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”
  7. 19407

    Table 7_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…In horses, two multivariable models explained the maximum amount of data variability. Model 1 demonstrated increased odds of seropositivity in mares [odds ratio (OR) = 2.90 95% CI 1.70–4.95, p < 0.001] and decreased odds in horses <2.5 years (OR = 0.46 95% CI 0.22–0.95, p = 0.04; reference: ≥4.5 years). …”
  8. 19408

    Effect of soil and plant nutrients on starch yield of potato for processing under growers’ management in Hokkaido, Japan by Marc Mwungura (22148585)

    Published 2025
    “…It was conducted in two phases: (1) a field survey of 16 growers, where soil, shoot, and tuber samples were collected and analyzed, and (2) a field experiment testing two levels of N (60 and 120 kg ha<sup>−1</sup>) and Mg (0 and 40 kg ha<sup>−1</sup>). …”
  9. 19409
  10. 19410

    Image 2_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

    Published 2025
    “…Compared to the control mouse line, DU6 mice exhibited significantly fewer CD4<sup>+</sup> and CD8<sup>+</sup> T cells, alongside a markedly higher proportion of macrophages and Gr-1<sup>+</sup>CD11b<sup>+</sup> myeloid-derived suppressor cells. …”
  11. 19411

    Table 2_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

    Published 2025
    “…Compared to the control mouse line, DU6 mice exhibited significantly fewer CD4<sup>+</sup> and CD8<sup>+</sup> T cells, alongside a markedly higher proportion of macrophages and Gr-1<sup>+</sup>CD11b<sup>+</sup> myeloid-derived suppressor cells. …”
  12. 19412
  13. 19413

    Table 4_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

    Published 2025
    “…Compared to the control mouse line, DU6 mice exhibited significantly fewer CD4<sup>+</sup> and CD8<sup>+</sup> T cells, alongside a markedly higher proportion of macrophages and Gr-1<sup>+</sup>CD11b<sup>+</sup> myeloid-derived suppressor cells. …”
  14. 19414

    Table 3_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

    Published 2025
    “…Compared to the control mouse line, DU6 mice exhibited significantly fewer CD4<sup>+</sup> and CD8<sup>+</sup> T cells, alongside a markedly higher proportion of macrophages and Gr-1<sup>+</sup>CD11b<sup>+</sup> myeloid-derived suppressor cells. …”
  15. 19415
  16. 19416

    Table 5_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

    Published 2025
    “…Compared to the control mouse line, DU6 mice exhibited significantly fewer CD4<sup>+</sup> and CD8<sup>+</sup> T cells, alongside a markedly higher proportion of macrophages and Gr-1<sup>+</sup>CD11b<sup>+</sup> myeloid-derived suppressor cells. …”
  17. 19417

    DNA damage protecting effects of EAExCC. by Srabonti Saha (17452756)

    Published 2025
    “…The extracts significantly decreased pro-inflammatory mediators and cytokines in LPS-activated macrophages. …”
  18. 19418

    Effects of extracts on body weight. by Srabonti Saha (17452756)

    Published 2025
    “…The extracts significantly decreased pro-inflammatory mediators and cytokines in LPS-activated macrophages. …”
  19. 19419

    The composition of milk used with the treatment. by Srabonti Saha (17452756)

    Published 2025
    “…The extracts significantly decreased pro-inflammatory mediators and cytokines in LPS-activated macrophages. …”
  20. 19420

    DNA damage protecting effects of MEExCC. by Srabonti Saha (17452756)

    Published 2025
    “…The extracts significantly decreased pro-inflammatory mediators and cytokines in LPS-activated macrophages. …”